Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$333K Sell
3,284
-5,956
-64% -$682K 0.1% 432
2026
Q2
$1.09M Buy
9,240
+652
+8% +$75.3K 0.32% 31
2026
Q1
$1.03M Buy
8,588
+1,953
+29% +$256K 0.3% 23
2025
Q4
$904K Buy
+6,635
New +$954K 0.3% 44

Other funds holding XYL

AlphaGrep UK's XYL Position: Q3 2026 in Review

AlphaGrep UK reduced its Xylem (XYL) stake by 64% in Q3 2026, selling an estimated $682K and leaving 3,284 shares worth $333K. The position accounts for 0.1% of the portfolio, ranked #432.

AlphaGrep UK first reported a position in XYL in Q4 2025 and has held it in 4 quarters since. The position peaked at $1.09M in Q2 2026. 906 funds tracked by Wall St. Rank hold XYL as of Q3 2026.

  • AlphaGrep UK held 3,284 shares of Xylem worth $333K as of Q3 2026.
  • AlphaGrep UK sold 5,956 Xylem shares in Q3 2026, an estimated $682K.
  • Xylem made up 0.1% of AlphaGrep UK's portfolio in Q3 2026, its #432 holding.
  • AlphaGrep UK first reported a position in Xylem in Q4 2025 and has held it in 4 quarters since.
  • AlphaGrep UK's Xylem position peaked at $1.09M in Q2 2026.
  • 906 funds tracked by Wall St. Rank held Xylem as of Q3 2026.

Based on AlphaGrep UK's 13F filing for Q3 2026, filed 12 Nov 2026.